A new study reports people may lose awareness of their memory loss almost three years prior to Alzheimer's disease setting in.
Researchers report retinal degeneration could be one of the earliest signs of FTD in people who have a genetic risk for the disorder.
Performing post-mortem staging of the brains and spinal cord tissue of patients with ALS, researchers discover the neurodegenerative disease could progress from one start point in the CNS to other regions of the brain and spinal cord.
Researchers have developed a new model to study neurodegenerative diseases which affect motor neurons, such as ALS.
Study reports protein aggregates within cells are cleared out by the endocytosis process. The findings could help with the development of new treatments for ALS.
c9ASO, an investigational ASO drug, targets the TDP-43 protein, reducing its buildup and decreasing neurological decline associated with ALS and FTD.
Researchers have discovered how a molecular scaffold, that allows key parts of cells to interact, comes apart in some neurodegenerative diseases.
A new mouse model has been developed that captures the pathology of sporadic neurodegenerative diseases.
A new study cancer suppression proteins play key roles in the progression of ALS.
A new study sheds light on how some forms of motor neuron disease begins and progresses at a cellular level.
Researchers believe mouse could provide a new platform for testing treatments for several neurodegenerative diseases.
Findings point to microglial TREM2 as a potential target for the treatment of ALS.
